Dewi Harjanto
Fidelity Biosciences (United States)(US)
Publications by Year
Research Areas
vaccines and immunoinformatics approaches, SARS-CoV-2 and COVID-19 Research, Immunotherapy and Immune Responses, Influenza Virus Research Studies, Cellular Mechanics and Interactions
Most-Cited Works
- → A Phase Ib Trial of Personalized Neoantigen Therapy Plus Anti-PD-1 in Patients with Advanced Melanoma, Non-small Cell Lung Cancer, or Bladder Cancer(2020)716 cited
- → Defining HLA-II Ligand Processing and Binding Rules with Mass Spectrometry Enhances Cancer Epitope Prediction(2019)254 cited
- → Sequence-based prediction of SARS-CoV-2 vaccine targets using a mass spectrometry-based bioinformatics predictor identifies immunogenic T cell epitopes(2020)100 cited
- → The T-cell-directed vaccine BNT162b4 encoding conserved non-spike antigens protects animals from severe SARS-CoV-2 infection(2023)88 cited
- → Quantitative Analysis of the Effect of Cancer Invasiveness and Collagen Concentration on 3D Matrix Remodeling(2011)60 cited
- → Matrix mechanics and receptor–ligand interactions in cell adhesion(2009)49 cited
- → Loss of APOBEC1 RNA-editing function in microglia exacerbates age-related CNS pathophysiology(2017)46 cited
- → RNA editing generates cellular subsets with diverse sequence within populations(2016)44 cited
- → Epitranscriptomic profiling across cell types reveals associations between APOBEC1-mediated RNA editing, gene expression outcomes, and cellular function(2017)41 cited
- → Modeling Extracellular Matrix Reorganization in 3D Environments(2013)39 cited